GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » ANGLE PLC (OTCPK:ANPCF) » Definitions » Buyback Yield %

ANGLE (ANPCF) Buyback Yield % : -30.31 (As of May. 16, 2024)


View and export this data going back to 2014. Start your Free Trial

What is ANGLE Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

ANGLE's current buyback yield was -30.31%.


ANGLE Buyback Yield % Historical Data

The historical data trend for ANGLE's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANGLE Buyback Yield % Chart

ANGLE Annual Data
Trend Apr13 Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -27.92 -16.75 -17.21 -6.73 -17.12

ANGLE Semi-Annual Data
Oct13 Apr14 Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.15 -13.38 -0.07 -34.08 -0.03

Competitive Comparison of ANGLE's Buyback Yield %

For the Diagnostics & Research subindustry, ANGLE's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ANGLE's Buyback Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, ANGLE's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where ANGLE's Buyback Yield % falls into.



ANGLE Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

ANGLE's Buyback Yield for the fiscal year that ended in Dec. 2022 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 23.197) / 135.50212
=-17.12%

ANGLE's annualized Buyback Yield for the quarter that ended in Jun. 2023 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 0.018) * 2 / 135.50212
=-0.03%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized semi-annual data, the Repurchase of Stock and Issuance of Stock data used here is two times the semi-annual (Jun. 2023) data.


ANGLE Buyback Yield % Related Terms

Thank you for viewing the detailed overview of ANGLE's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


ANGLE (ANPCF) Business Description

Traded in Other Exchanges
Address
10 Nugent Road, The Surrey Research Park, Surrey, Guildford, GBR, GU2 7AF
ANGLE PLC is active in the healthcare sector in the United Kingdom. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, of which majority of its revenue is generated from Europe.

ANGLE (ANPCF) Headlines

From GuruFocus

Angle PLC Announces Holding(s) in Company - (2)

By ACCESSWIRE ACCESSWIRE 07-08-2020

Angle PLC Announces Exercise of Options and Total Voting Rights

By ACCESSWIRE ACCESSWIRE 04-30-2021

Angle PLC Announces Holding(s) in Company - (1)

By ACCESSWIRE ACCESSWIRE 07-08-2020

Angle PLC Announces AACR 2019

By ACCESSWIRE AccessWire 04-12-2019